Search details
1.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38561010
2.
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Future Oncol
; 19(26): 1769-1776, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37439181
3.
International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma.
Acta Oncol
; 61(6): 672-679, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35139735
4.
Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
Support Care Cancer
; 29(12): 7577-7586, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34120247
5.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Lancet Oncol
; 21(9): 1173-1187, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32758455
6.
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Future Oncol
; 16(18): 1235-1243, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32490686
7.
Sexual quality of life evaluation after treatment among women with breast cancer under 35 years old.
Support Care Cancer
; 27(3): 879-885, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30116944
8.
Prospective study of a web-mediated management of febrile neutropenia related to chemotherapy (Bioconnect).
Support Care Cancer
; 27(6): 2189-2194, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30306327
9.
Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
Oncology
; 95(3): 188-191, 2018.
Article
in English
| MEDLINE | ID: mdl-29847828
10.
Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.
Support Care Cancer
; 26(6): 1897-1903, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29275524
11.
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.
Ther Drug Monit
; 38(5): 567-72, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27631463
12.
Correction to: Effectiveness of naloxegol in patients with cancer pain suffering from opioidinduced constipation.
Support Care Cancer
; 29(12): 7587-7589, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34387729
13.
Effects and consequences of Digisonic SP cochlear implant on radiotherapy planning.
Eur Arch Otorhinolaryngol
; 272(7): 1597-603, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-24599596
14.
Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up.
Support Care Cancer
; 22(6): 1467-73, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24414998
15.
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Lancet Healthy Longev
; 5(6): e392-e405, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38759667
16.
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Lancet Healthy Longev
; 5(3): e182-e193, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38432247
17.
Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view.
Phys Med
; 109: 102568, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37015168
18.
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Clin Transl Radiat Oncol
; 40: 100613, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36968576
19.
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Eur J Cancer
; 183: 24-37, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36796234
20.
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
JMIR Res Protoc
; 11(11): e40969, 2022 Nov 25.
Article
in English
| MEDLINE | ID: mdl-36427234